AIDX
20/20 Biolabs, Inc.
$1.54+0.01 (0.65%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
20/20 Biolabs, Inc. (AIDX) is a publicly traded company with 8 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 7 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
8 transactions (past 365 days)
| 2026-04-06 | 2026-04-02 | Bergman Alan B. | CFO | Award | 100,000 | $1.88 | $188,000 |
| 2026-04-06 | 2026-04-02 | Zhou Jiming | COO | Award | 150,000 | $1.88 | $282,000 |
| 2026-03-04 | 2026-03-03 | Cohen Jonathan M | CEO | Award | 352,936 | $3.39 | $1,196,453 |
| 2026-02-24 | 2026-02-19 | Rollins John Woodson | Director | Conversion | 13,029 | $0.00 | $0 |
| 2026-02-24 | 2026-02-19 | Rollins John Woodson | Director | Conversion | 6,135 | $0.00 | $0 |
| 2026-02-23 | 2026-02-19 | Ross Michael A. | Director | Conversion | 31 | $0.00 | $0 |
| 2026-02-23 | 2026-02-19 | Compton John G. | Director | Conversion | 7,669 | $0.00 | $0 |
| 2026-02-23 | 2026-02-19 | Cohen Richard M | Director | Conversion | 7,700 | $0.00 | $0 |